The revised annual report for the financial year 2024-25 is enclosed
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Boston Bio Systems Limited has filed a revised annual report for FY 2024-25 along with the notice for its 30th Annual General Meeting scheduled for 30th September 2025 via video conferencing. The company is proposing a name change to 'Boston Commerce Limited' and is expanding its business objects to include IT services, agriculture, real estate, trading, e-commerce, and quick commerce operations. Shareholders will be asked to approve the appointment of M/s Sunit M Chhatbar & Co. as statutory auditors to fill the casual vacancy caused by the resignation of M/s Nahar V. & Co. during the year. Other key proposals include increasing borrowing limits to Rs. 50 crores, authorizing loans and guarantees up to Rs. 50 crores under Section 186, and a change in designation of Mr. Ghanshyam Gavali from Executive Director to Managing Director.
The mid-year auditor change and the move to diversify into commerce, real estate, and agriculture represent a significant strategic pivot for the company. Shareholders should review the revised financials carefully, as restated reports can sometimes signal accounting adjustments, while the expanded borrowing limit and diversification plans could materially alter the company's risk profile.